- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pro Medicus Ltd (PME)
The Pro Medicus Ltd share price today is 197.07, view ASX PME stock exchange data. Track the latest Pro Medicus Ltd share price with real-time updates on PME stock performance including market cap, day range, 52-week range and dividend yield. Access PME charts, earnings dates and analyst estimates to support your investment decisions.
197.07
-13.35(-6.34%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
195.01
209.49
52 wk Range
107.75
336.00
PME is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
195.01209.49
52 wk Range
107.75336.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PME Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
190.74
Downside
-3.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
11 Buy
3 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 190.74
(-3.21% Downside)
Pro Medicus Ltd Earnings Call Summary for H1/2026
- Pro Medicus reported record H1 2026 performance with 28.4% revenue growth and ~30% increase in underlying EBIT, though stock fell 19.71% post-announcement.
- Interim dividend increased by 28% to AUD 0.32 per share, fully franked, with cash and investments up 5.3%.
- Company launched new cardiology suite, expanded AI capabilities, and is developing digital pathology products as part of its enterprise imaging strategy.
- CEO Dr. Sam Hupert projects forward revenue to exceed AUD 1 billion over next five years, with expectations for stronger H2 FY2026 performance.
- Management views AI integration as 'a plus rather than a threat,' focusing on both proprietary AI development and strategic third-party partnerships.
Last Updated: 12-02-2026, 07:12 am
Read Full TranscriptEarnings
Latest Release
03-06-2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare PME to Peers and Sector
Metrics to compare | PME | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPMEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 87.7x | 18.7x | −0.4x | |
PEG Ratio | 0.63 | 0.12 | 0.00 | |
Price/Book | 52.9x | 2.0x | 2.6x | |
Price / LTM Sales | 85.6x | 1.7x | 3.0x | |
Upside (Analyst Target) | 1.5% | 27.3% | 51.5% | |
Fair Value Upside | Unlock | 18.0% | 8.8% | Unlock |
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Pro Medicus Ltd (PME) Share Price Today?
The Pro Medicus Ltd share price today is 197.07.
What is the current Pro Medicus Ltd (PME) share price and day range?
As of 11-07-2026, the Pro Medicus Ltd share price is 197.07, with a previous close of 210.42. The share price has ranged from 195.01 to 209.49 today, while the 52-week range spans from 107.75 to 336.00.
What Is the Pro Medicus Ltd Market Cap?
As of today, Pro Medicus Ltd market cap is 20.59B.
Does Pro Medicus Ltd Pay Dividends? What's The Current Dividend Yield?
The Pro Medicus Ltd dividend yield is 0.29%.
What Is the Pro Medicus Ltd (PME) Share Price Target?
The average 12-month share price target for Pro Medicus Ltd is 190.74, with a high estimate of 250 and a low estimate of 54. 11 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and -3.21% Downside potential.
What Is Pro Medicus Ltd's Earnings Per Share (TTM)?
The Pro Medicus Ltd EPS (TTM) is 2.24.
When Is the Next Pro Medicus Ltd Earnings Date?
Pro Medicus Ltd will release its next earnings report on 19-08-2026.
From a Technical Analysis Perspective, Is PME a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Pro Medicus Ltd Trade On?
Pro Medicus Ltd is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Pro Medicus Ltd?
The stock symbol for Pro Medicus Ltd is "PME."
How Many Times Has Pro Medicus Ltd Stock Split?
Pro Medicus Ltd has split 0 times.
How Many Employees Does Pro Medicus Ltd Have?
Pro Medicus Ltd has 132 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.